The amygdala is known to regulate neuroendocrine and behavioral responses to a variety of stimuli. Herpes simplex virus-1 (HSV-1) is the common cause of viral encephalitis, manifested by hypothalamic-pituitary-adrenal (HPA) axis activation, fever, hypermotor activity and aggression. We examined here the role of the central amygdala (cAMG) in regulating the HPA axis function, febrile and behavioral responses to HSV-1 infection in rats. Bilateral electrolytic lesions were performed in the cAMG. HSV-1 encephalitis was induced by intracerebroventricular (ICV) inoculation of purified virions. Motor activity and body temperature were examined by a biotelemetric system. ICV inoculation of HSV-1 caused a marked time-dependent increase in serum corticotropin (ACTH) and corticosterone at 4 and 24 h post-infection. These responses were attenuated in rats with bilateral lesions of the cAMG. HSV-1 infection induced fever, motor hyperactivity and aggressive behavior. These responses were also attenuated in rats with cAMG lesions. The cAMG plays an important role in mediating the neuroendocrine, febrile and behavioral responses to HSV-1 infection.

Keywords:
Herpes simplex virus encephalitis, HSV-1 infection, Hyperthermia, Corticotropin, Behavioral Neuroendocrinology, Amygdala
1.
Ben-Hur T, Conforti N, Itzik A, Weidenfeld J: Effects of HSV-1, a neurotropic virus, on the hypothalamic-pituitary-adrenocortical axis in rats. Brain Res 1995;702:17–22.
2.
Ben-Hur T, Rosenthal J, Itzik A, Weidenfeld J: Rescue of HSV-1 neurovirulence is associated with induction of brain interleukin-1 expression, prostaglandin synthesis and neuroendocrine responses. J Neurovirol 1996;2:279–288.
3.
Ben-Hur T, Cialic R, Itzik A, Barak O, Yirmiya R, Weidenfeld J: A novel permissive role for glucocorticoids in induction of febrile and behavioral signs of experimental herpes simplex virus encephalitis. Neuroscience 2001;108:119–127.
4.
Ben-Hur T, Itzik A, Barak O, Asher Y, Becker Y, Yirmiya R, et al: Immunization with a nonpathogenic HSV-1 strain prevents clinical and neuroendocrine changes of experimental HSV-1 encephalitis. J Neuroimmunol 2004;152:5–10.
5.
Ben Hur T, Rosenthal J, Itzik A, Weidenfeld J: Adrenocortical activation by herpes virus: involvement of IL-1β and central noradrenergic system. Neuroreport 1996;7:927–931.
6.
Feldman S, Conforti N, Weidenfeld J: Limbic pathways and hypothalamic neurotransmitters mediating adrenocortical responses to neural stimuli. Neurosci Biobehav Rev 1995;19:235–240.
7.
Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi DC, et al: Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol 2003;24:151–180.
8.
Feldman S, Conforti N, Itzik A, Weidenfeld J: The role of limbic structures in the modulation of ACTH responses following adrenalectomy. Ann NY Acad Sci 1995;771:73–81.
9.
Xu Y, Day TA, Buller KM: The central amygdala modulates hypothalamic-pituitary-adrenal axis responses to systemic interleukin-1β administration. Neuroscience 1999;94:175–183.
10.
Ben-Hur T, Cialic R, Itzik A, Yirmiya R, Weidenfeld J: Acute effects of purified and UV-inactivated herpes simplex virus type 1 on the hypothalamo-pituitary-adrenocortical axis. Neuroendocrinology 2001;74:160–166.
11.
Paxinos G, Franklin, KBJ: The Rat Brain in Stereotaxic Coordinates. Sydney, Academic Press, 1982.
12.
Van de Kar LD, Blair ML: Forebrain pathways mediating stress-induced hormone secretion. Front Neuroendocrinol 1999;20:1–48.
13.
Peyron C, Petit JM, Rampon C, Jouvet M, Luppi PH: Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods. Neuroscience 1998;82:443–468.
14.
Jedema HP, Grace AA: Corticotropin-releasing hormone directly activates noradrenergic neurons of the locus ceruleus recorded in vitro. J Neurosci 2004;24:9703–9713.
15.
Van Bockstaele EJ, Bajic D, Proudfit H, Valentino RJ: Topographic architecture of stress-related pathways targeting the noradrenergic locus coeruleus. Physiol Behav 2001;73:273–283.
16.
Weidenfeld J, Newman ME, Itzik A, Gur E, Feldman S: The amygdala regulates the pituitary-adrenocortical response and release of hypothalamic serotonin following electrical stimulation of the dorsal raphe nucleus in the rat. Neuroendocrinology 2002;76:63–69.
17.
Weidenfeld J, Abramsky O, Ovadia H: Evidence for the involvement of the central adrenergic system in interleukin-1-induced adrenocortical response. Neuropharmacology 1989;28:1411–1414.
18.
Chuluyan HE, Saphier D, Rohn WM, Dunn AJ: Noradrenergic innervation of the hypothalamus participates in adrenocortical responses to interleukin-1. Neuroendocrinology 1992;56:106–111.
19.
Beaulieu S, Di Paolo T, Cote J, Barden N: Participation of the central amygdaloid nucleus in the response of adrenocorticotropin secretion to immobilization stress: opposing roles of the noradrenergic and dopaminergic systems. Neuroendocrinology 1987;45:37–46.
20.
Federico P, Malkinson TJ, Cooper KE, Pittman QJ, Veale WL: Vasopressin perfusion within the medial amygdaloid nucleus attenuates prostaglandin fever in the urethane-anaesthetized rat. Brain Res 1992;587:319–326.
21.
Hare AS, Clarke G, Tolchard S: Bacterial lipopolysaccharide-induced changes in FOS protein expression in the rat brain: correlation with thermoregulatory changes and plasma corticosterone. J Neuroendocrinol 1995;7:791–799.
22.
Tkacs NC, Li J, Strack AM: Central amygdala Fos expression during hypotensive or febrile, nonhypotensive endotoxemia in conscious rats. J Comp Neurol 1997;379:592–602.
23.
Pittman QJ, Chen X, Mouihate A, Hirasawa M, Martin S: Arginine vasopressin, fever and temperature regulation. Prog Brain Res 1998;119:383–392.
24.
Ovadia H, Abramsky O, Weidenfeld J: Evidence for the involvement of the central adrenergic system in the febrile response induced by interleukin-1 in rats. J Neuroimmunol 1989;25:109–116.
25.
Barnett EM, Cassell MD, Perlman S: Two neurotropic viruses, herpes simplex virus type 1 and mouse hepatitis virus, spread along different neural pathways from the main olfactory bulb. Neuroscience 1993;57:1007–1025.
26.
Paivarinta MA, Marttila RJ, Koulu M, Pesonen U, Roytta M, Rinne UK: Brain monoamine metabolism and rotational behaviour induced by experimental herpes simplex virus encephalitis. J Neural Transm Gen Sect 1991;86:181–190.
27.
Walker DL, Davis M: Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J Neurosci 1997;17:9375–9383.
28.
Caparros-Lefebvre D, Girard-Buttaz I, Reboul S, Lebert F, Cabaret M, Verier A, et al: Cognitive and psychiatric impairment in herpes simplex virus encephalitis suggest involvement of the amygdalo-frontal pathways. J Neurol 1996;243:248–256.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.